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Abstract
Background: Tobacco and alcohol are recognised as the major risk factors for both oral cavity (mouth) and
oropharyngeal (throat) cancers, with increasing acceptance of the role of human papillomavirus (HPV) in the
aetiology of oropharyngeal cancers. In addition, there is a significant increased risk for oral cancer among lower
socioeconomic groups, males and older age groups. There is a growing evidence for the potential role of primary
care professionals in smoking cessation and reducing alcohol-related harm. However, there are uncertainties about
the best approaches/strategies to assess risk factors associated with oral cancer, effective components of preventive
interventions for behaviour change and implementation strategies in primary care dental settings. Thus, in order to
contribute to the prevention of oral cancer effectively, dental professionals need to assess patients on the major risk
factors (tobacco, alcohol and HPV/sexual behaviours) and deliver appropriate prevention, taking into account the
patient’s sociodemographic context.
Aim: The study aims to synthesise evidence on the best practice for undertaking an assessment of major behavioural
risk factors associated with oral cancer and delivering effective behaviour change preventive interventions (e.g. advice,
counselling, patient recall, signposting/referral to preventive services) by dental professionals in primary care dental
settings.
Method: The study involves a systematic review and evidence appraisal. We will search for clinical guidelines
and systematic reviews from the following databases: Cochrane Library, Ovid MEDLINE, EMBASE, Web of Science,
PsychINFO, PubMed, TRIP and Google Scholar. We will also search websites of professional organisations/agencies
and bibliographies/reference lists of selected papers. Quality will be assessed with the AGREE II (Appraisal of Guidelines
for Research & Evaluation II) instrument for included clinical guidelines and the AMSTAR (A Measurement Tool to
Assess Systematic Reviews) and ROBIS instruments for included systematic reviews. The best practice evidence will be
assessed via a narrative synthesis of extracted data, considering publication quality.
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Discussion: This systematic review will synthesise evidence on the best practice for oral cancer risk factor assessment
and prevention and evaluate the relationship between available clinical guidelines and the review evidence base.
This collation of evidence will be useful for making recommendations for future intervention, research and guideline
development.
Systematic review registration: PROSPERO CRD42015025289
Keywords: Oral cavity cancer, Oropharyngeal cancer, Risk factors, Prevention, Primary care, Dental professionals,
Clinical guidelines, Systematic reviews
Background
Oral cancer
The term oral cancer broadly includes oral cavity (mouth)
and oropharyngeal (throat) cancers, and consensus on the
definition is emerging [1]. Based on the World Health
Organisation (WHO) International Statistical Classification
of Diseases and Related Health Problems 10th revision
(ICD-10) coding, oral cavity cancer include cancers of the
lip (excluding external surface) (C00.3-C00.9), other and
unspecified parts of tongue (C02, excluding C02.4), the
gum (C03), floor of mouth (C04), palate (C05), other and
unspecified parts of mouth (C06), but not cancers of the
salivary glands. Oropharyngeal cancer include cancers
of the base of tongue (C01), lingual tonsil (C2.4),
tonsil (C9.0-9.9), oropharynx (C10.0-10.9), pharynx not
otherwise specified (C14.0) and waldeyer ring (C14.2) [2].
The World Cancer Report 2014 has oral cavity and oro-
pharyngeal cancers combined as the seventh most com-
monly occurring cancer, and in terms of mortality, they
rank 9th in the world [3]. In 2012, approximately 442,760
new oral cancer cases were diagnosed, with 241,418
deaths reported worldwide [4]. The incidence of oral
cavity cancer has marginally increased or stayed stable
across the world, whilst oropharyngeal cancer incidence is
among the most rapidly increasing in both men and
women, and in younger age groups (age ˂60 years) [1]. In
Scotland, oropharyngeal cancer rates are now higher than
cervical cancer, melanoma of the skin and adenocarcin-
oma of the oesophagus [5].
Oral cancer survival is linked to stage at diagnosis [6],
and there are persistent concerns about missed opportun-
ities for early referral [7, 8]. The General Dental Council
(GDC) has recently identified improved oral cancer detec-
tion as a recommended area for the Continuing Profes-
sional Development (CPD) of dental professionals [9].
Moreover, the GDC has an expectation that practitioners
deliver oral cancer prevention. In a recent hearing, a den-
tist was placed under supervision for failing to ensure that
a patient with ulceration was urgently referred to a spe-
cialist, but also for a cited charge that the dentist ‘failed to
ensure that Patient A [who smoked 10-15 cigarettes a day]
was provided with smoking cessation advice’ [9].
Risk factors
Oral cancer aetiology is multifactorial and the major risk
factors can be categorised as modifiable (behavioural) and
non-modifiable (sociodemographic) (see Table 1) [10, 11].
There is an explicit evidence establishing tobacco
smoking [12] and alcohol drinking [13] as the major risk
factors in oral cancer development. The risk of develop-
ing oral cancer increases with frequency (i.e. numbers of
cigarettes or drinks per day or week) and duration (i.e.
years of smoking or drinking) of tobacco and alcohol use
[10]. In addition, oral cavity cancer risk is increased by
using smokeless tobacco (snuff; chewing betel quid with
or without tobacco) [10, 14], and again the risk increases
with the quantity and duration of consumption [14].
Pooled data analysis from the International Head and
Neck Cancer Epidemiology Consortium (INHANCE)
found that the combined effects of tobacco and alcohol
use are greater than the multiple of their individual ef-
fects on the risk of developing oral cancer [15]. Thus,
the majority of oral cavity (64 %), pharyngeal (72 %), and
laryngeal cancers (89 %) are associated with these be-
haviours combined [15]. Another INHANCE study con-
cluded that a beneficial effect on reducing oral cancer
risk was observed following smoking cessation and quit-
ting alcohol drinking [16].
Recent evidence from studies conducted in the USA
shows increased oral cancer rates, particularly oropharyn-
geal cancer, which are thought to be partly attributable to
the human papillomavirus (HPV) and especially HPV16
which is sexually transmitted [17, 18]. An INHANCE
analysis found an increased oropharyngeal cancer risk
associated with certain sexual behaviours, i.e. history of
having six or more sexual partners, four or more oral sex
Table 1 Major recognised oral cancer risk factors
Modifiable (behavioural) Non-modifiable (sociodemographic)
Tobacco smoking Socioeconomic status (lower)
Alcohol Age (older)
Smokeless tobacco
(areca/betel nut)
Gender (males)
HPV/sexual behaviours
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partners, an earlier age at sexual debut and same-sex
sexual contact [17].
In addition to behavioural risk factors, the major non-
modifiable risk factors include socioeconomic status, age
and gender [10, 19]. According to a large INHANCE
pooled data analysis, lower education status and lower
income have been implicated as important oral cancer
risk factors, independent of behavioural risk factors [20].
Moreover, oral cancer is more common in males than in
females, with two thirds of oral cavity cancer cases
occurring in men worldwide [4]. Whilst there is also an
increased risk for oral cancer among older age groups,
with the majority of cases occurring in people aged 50
or over [4]. A further INHANCE study compared the
role of major oral cancer risk factors (tobacco smoking
and alcohol drinking) in younger adults and older adults
and found a positive association with oral cancer and
these major risk factors, independent of age [21].
Prevention
Following the identification of risk, preventive interven-
tions available to dental professionals include advice,
behavioural counselling, adjusted patient recall intervals
and/or signposting/referral to preventive services. The
main current focus of preventive strategies is the
delivery of a ‘brief intervention’, which is defined as
5-15 min of motivational and/or supportive discussion
akin to basic counselling [22]. For example in Scotland,
the Government’s smoking and alcohol strategy includes
the delivery of brief interventions through primary care
professionals and outlines the cost-effectiveness of these
interventions, especially when combined with referral
to specialist cessation services [23, 24]. However, it is
often still hard to establish which components of
interventions are most effective, particularly in dental
practice settings [25].
Given the growing acceptance of the role of HPV in the
aetiology (and HPV testing in the management) of
oropharyngeal cancers, the implications for patient/social
history taking in oral health assessment and for patient
counselling needs to be considered [26]. For example, ac-
cording to the Centers for Disease Control and Prevention
HPV guidelines, behavioural counselling on safer sexual
practices (i.e. lifetime mutual monogamy, condom use and
fewer sexual partners) plays an important role in oropha-
ryngeal cancer prevention [27].
Common and multiple risk factors
The behavioural risk factors implicated in oral cancer
risk are also associated with a wide range of diseases
(such as heart disease, cancer, diabetes, stroke and other
oral diseases); hence tobacco, alcohol and socioeconomic
status in particular are known as common risk factors
[28]. The associated common risk factor approach
recognises that dental professionals can contribute to
improve not only oral health but also general health.
The WHO has supported this approach at a global level,
and an effective oral cancer prevention strategy may
have benefits that are not limited to this particular
condition alone [28, 29].
Consideration also needs to be given to focusing on the
presence of multiple risk factors in individuals, i.e. clus-
tering of unhealthy behaviours and socioeconomic factors.
Research has shown that risk factors (for example,
smoking, alcohol, poor diet and physical inactivity) occur
in combinations and show multiplicative interactions and
are strongly associated with poorer socioeconomic envi-
ronments [30]. This is particularly relevant to oral cancer
prevention where there is a synergistic relationship be-
tween multiple risk factors, with smoking and alcohol in
combination magnifying the risk for oral cancer [15].
Communicating risks associated with oral cancer is a key
challenge for dental professionals and can help in changing
behaviour and/or improving patient decision-making [31].
One of the strategies to promote positive health behaviour
change is to identify/create a ‘teachable moment’, which is
an opportunity to implement preventive interventions [32].
There is a need to determine which teachable moments
are present (or could be created) to allow dental profes-
sionals to provide effective oral cancer risk communica-
tion, and therefore should be recommended the best
practice [31, 32].
There is a plethora of guidance and recommendations
available for dental professionals regarding the causes of
oral cancer worldwide [10, 33] and also for the early de-
tection, effective treatment and palliative care of oral can-
cer cases [33]. The current evidence also shows the
importance of dental professionals in providing preventive
advice. However, initial literature searching, plus detailed
discussions with specialists in Oral Medicine, Dental
Public Health, the International Head and Neck Cancer
Epidemiology Consortium (INHANCE), Postgraduate
Dental Education specialists (NHS Education Scotland)
and Clinical Effectiveness groups identified potential un-
certainties [34] about the best approaches/strategies to as-
sess risk factors associated with oral cancer [33], effective
components of preventive interventions for behaviour
change (i.e. what are the ‘Active ingredients’/mechanisms)
[25, 33, 35], and implementation strategies (i.e. ‘how to do’
rather than ‘what to do’) [36] in the primary care dental
settings.
This established a clear need to more clearly present
details of evidence-based approaches for risk factor
assessment and prevention for dental professionals for
effective behaviour change to benefit those at the highest
risk of oral cavity and oropharyngeal cancer (e.g. tobacco
cessation, reduced alcohol consumption and safer sexual
practices). Thus, this systematic review involves identifying
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and appraising evidence for the best practice in oral cancer
risk assessment and the delivering of preventive interven-
tions for effective behaviour change. It does not cover
screening and oral examination (e.g. for early detection).
Aims/objectives
The study aims to synthesise evidence on the best prac-
tice for undertaking an assessment of major behavioural
risk factors associated with oral cancer and delivering
effective behaviour change preventive interventions (e.g.
advice, counselling, patient recall, signposting/referral to
preventive services) by dental professionals in primary
care dental settings.
Specific research questions for this systematic review in
accordance with the PICOS (participants, intervention,
comparator, outcomes, and setting) format are [37, 38] the
following:
1. What methods for assessing major behavioural risk
factors associated with oral cancer delivered by dental
professionals on patients visiting primary care dental
settings are considered the best practice and what
are recommendations for associated preventive
interventions, including advice, counselling, patient
recall and signposting/referral to preventive services?
2. What methods for delivering preventive interventions
for major behavioural risk factors associated with oral
cancer by dental professionals on patients visiting
primary care dental settings are considered the best
practice for effective behaviour change?
Dental professionals here includes dentists, dental thera-
pists, dental hygienists, dental nurses and oral health edu-
cators in primary care dental settings (i.e. the first point of
contact in the health care system e.g. general dental prac-
tice and the public dental service; excluding secondary and
tertiary care settings). Identifying the best practice means
appraising approaches/strategies that are best supported in
terms of evidence for their effectiveness and efficiency [39].
Method
This systematic review is registered with PROSPERO
(registration number CRD42015025289). The PRISMA-P
2015 statement for systematic review protocols has been
consulted for writing this protocol [37, 38]. The PRISMA-P
2015 checklist is provided in Additional file 1. Other similar
systematic reviews of reviews and/or guidelines have been
referred to for convention, e.g. Álvarez-Bueno et al. [40],
Koes et al. [41], Al-Ansary et al. [42] and Damery et al. [43].
Eligibility criteria
Types of studies
Clinical guidelines (published/e-learning) and systematic
reviews or meta-analyses (of randomised and non-
randomised studies) available worldwide will be included
in this systematic review. The included clinical guidelines,
recognised by a national governmental or provider organ-
isation, will comprise recommendations or the best prac-
tice related to risk factors associated with oral cancer,
history taking, patient recall and delivery of preventive in-
terventions in the primary care (medical and dental) set-
ting. The included systematic reviews will contain evidence
for the effectiveness of interventions for addressing risk
factors associated with oral cancer and/or for preventive
interventions (delivered in the primary care setting).
We will not apply any language restrictions for identifying
clinical guidelines and systematic reviews. The non-English
papers will be translated to English with the help of the
University Translation Services department. Clinical guide-
lines will be limited to the last 10 years. There will be no
date restrictions for systematic reviews. Narrative/literature
reviews and systematic review protocols will be excluded.
Types of participants
Study participants/target groups include patients or sub-
jects of any age attending primary care who are at risk
of developing oral cavity or oropharyngeal cancers, i.e.
tobacco users, alcohol drinkers and those at risk of
developing HPV (e.g. history of having six or more
sexual partners, four or more oral sex partners, early
onset of sexual activity or same-sex sexual contact [17]).
Types of interventions
The review covers interventions by primary care profes-
sionals to assess risk and/or promote behaviour change.
Interventions could include advice, brief interventions,
behavioural counselling, patient recall and referral to
preventive services or any combination of these. We will
exclude screening interventions for the detection of oral
cancer (e.g. visual screening, visual staining using tolui-
dine blue, oral cytology using brush biopsies and fluores-
cence imaging and light-based techniques).
Types of outcome measures
The main outcomes of interest will be the following:
1. The best practice in oral cancer risk factor
assessment (e.g. how best to ask about behaviour/
assess risk/communicate risk)
2. The best practice in preventive interventions:
a) Description of evidence-based preventive interventions
(e.g. length and content of preventive interventions,
number of follow-up sessions, referral pathways)
b) Evidence for effectiveness of interventions, i.e.
changes in behaviours (e.g. decrease in tobacco or
alcohol consumption from baseline to follow-up)
c) Role of specific aspects such as combination
interventions (addressing multiple risks)
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Types of setting
The study includes primary care (medical and dental)
settings; secondary or tertiary care are not included in
this study.
Information sources
The literature search for clinical guidelines and systematic
reviews will be carried out in health and psychological
electronic databases: Cochrane Library, Ovid MEDLINE,
EMBASE, Web of Science, PsychINFO, PubMed, TRIP and
Google Scholar. An internet search of the websites of
health boards and relevant (professional, medical, dental,
public health, scientific) organisations/agencies will also
be carried out. A list of organisations/databases for
searching clinical guidelines has been provided in
Additional file 2. A dedicated University Librarian (HW-A)
will help to develop a bespoke protocol to allow identifica-
tion of clinical guidelines (published/e-learning) via web-
sites of relevant organisations/agencies and an Internet
Search Engine (Google). The bibliographies/reference lists
of identified documents will also be hand-searched for
additional references. Experts in the area have been con-
tacted and will help locate any unpublished and ongoing
research as the review proceeds in order to minimise pub-
lication bias.
Search strategy
The University Librarian (HW-A) has helped develop
the search strategy for identifying clinical guidelines and
systematic reviews. The initial search terms were identi-
fied from a scoping of literature and from MeSH subject
headings. In order to find all relevant data, the initial
search terms included are broad, drawing from across
primary care (both medical and dental practice setting).
Evidence will only be restricted to dental practice setting
if sufficient quality and quantity can be identified. Key
terms are prevention (e.g. advice, cessation, harm reduc-
tion, brief intervention, counselling); primary care (e.g.
General Dental Practice, General Medical Practice) and
risk factors (e.g. alcohol, tobacco, HPV). Various trunca-
tion symbols (for e.g. *, ?, $) and Boolean operators (for
e.g. AND, OR, proximity) will be used to refine the
search. We decided not to limit the search to oral can-
cer, because of not wanting to rule out good guidelines
and/or evidence on how to assess risk and deliver oral
cancer prevention that can be extrapolated from guide-
lines and/or reviews aimed at another clinical condition
(e.g. smoking cessation strategies targeting periodontal
disease) [44].
The InterTASC Information Specialists’ Sub-Group
(ISSG) search filter resource provides easy access to pub-
lished and unpublished search filters designed to retrieve
records by study design or focus [45]. Thus, in order to re-
trieve systematic reviews in Ovid MEDLINE and EMBASE,
the SIGN search filter will be used; whereas to retrieve
clinical guidelines in Ovid MEDLINE, the University of
Texas School of Public Health search filter will be used
[45]. The search will be limited to clinical guidelines and
systematic reviews by using the filters provided in the
databases Cochrane Library, PsychINFO, PubMed and
TRIP. In the Web of Science database, the search will be
limited to ‘Reviews’ (including literature reviews and sys-
tematic reviews), as there is no filter for systematic review
only. Using search filters will help in reducing the number
of articles to be screened whilst identifying higher quality
evidence and maximising specificity [46].
An example of the Ovid MEDLINE search strategy is
provided in Additional file 3. The MEDLINE search
strategy will be finalised first and then it will be adapted
for other databases. The SIGN search filters and the
University of Texas School of Public Health search filters
have been provided in Additional file 4.
Data management
In accordance with the Cochrane review group guide-
line, all steps in data management (review of titles and
abstracts, inclusion and exclusion decisions, data extrac-
tion, quality appraisal, assessing risk of bias, collating
themes for final synthesis) will be carried out independ-
ently by at least two members of the multidisciplinary
review team and discrepancies discussed with the wider
team [47]. If, after discussions between the review team,
uncertainties still persist, authors of the original studies
will be contacted to resolve disagreements.
Records from all searches will be combined, imported
into EndNote bibliographic software and duplicate re-
cords will be removed. Two investigators will independ-
ently review the title and abstract of all records against
the inclusion/exclusion criteria to select for full text re-
view. Disputed papers will be included at this stage. Full
text copies of selected clinical guidelines and systematic
reviews will be obtained and used to assess the eligibility
of the records to be included in the final systematic re-
view. Reasons for exclusion will be recorded and reported.
Where more than one eligible clinical guideline or sys-
tematic review of the same research data exists, we will
include the most recent publication.
To summarise, a PRISMA four-phase flow diagram will
be completed at the end of the study selection process.
The next steps will be to extract data from the clinical
guideline and systematic review strands for separate
synthesis and systematic quality assessment/risk of bias
exercises and finally to compare and contrast to give an
overview across the two streams.
Data extraction
The data extraction template will be adapted from the
Cochrane Collaboration [47] and the Centre for Reviews
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and Dissemination (CRD) at the University of York [48]
data extraction checklist. The data extraction form will
be pilot-tested on a small set of papers and refined to
ensure the correct sensitivity and specificity.
Details of information to be extracted from reviews and
guidelines, respectively, are provided in Additional file 5.
Quality assessment and risk of bias
Clinical guidelines
Quality assessment of the included clinical guidelines
will be carried out using the AGREE II (Appraisal of
Guidelines for Research & Evaluation II) instrument.
This consists of 23 key items in six domains and will be
used to assess the methodological rigour and transpar-
ency in the development of the included clinical guide-
lines [49]. Each domain helps to appraise the quality of
clinical guideline in a unique dimension, i.e. scope and
purpose, stakeholder involvement, rigour of develop-
ment, clarity of presentation, applicability and editorial
independence. This instrument also assigns each clinical
guideline an overall quality rating between 1 (lowest
possible quality) and 7 (highest possible quality), and
whether the user would recommend the guideline for
use in practice or not.
Systematic reviews
In order to assess the methodological quality of included
systematic reviews, the AMSTAR (A Measurement Tool
to Assess Systematic Reviews) instrument will be used
[50]. The AMSTAR checklist consists of 11 key items
designed to help systematically rate the quality of vari-
ous methodological aspects (e.g. an ‘a priori’ design, data
extraction by at least two independent reviewers, at least
two electronic sources searched, duplicate study selection
and assessment of publication bias) [50]. In addition, the
ROBIS tool will be used for assessing the risk of bias in
included systematic reviews [51]. This is a new tool which
is completed by assessing relevance, identifying concerns
with the review process and finally judging risk of bias.
Data synthesis
We will first keep the clinical guidelines and systematic
reviews as separate ‘streams’, and each will be synthesised
rigorously according to guidance on conducting system-
atic reviews [48]. Because included clinical guidelines
and systematic reviews are likely to be heterogeneous in
relation to included interventions, target populations,
methods, etc., we will focus on a thematic description of
each stream in line with our objectives.
The main steps in synthesis will be extraction and
organisation of data, analysis between and within risk
factors and professional groups and assessing robustness
of evidence and recommendations [48, 52, 53]. As an
integral component of each narrative synthesis, data will
be related to the quality assessment in order to illustrate
the strongest evidence among included clinical guide-
lines and systematic reviews [53].
Tables including a full description of included studies
(e.g. study quality, risk factors assessed, included inter-
ventions, study population and outcomes) will be pre-
sented to summarise the evidence. This will be followed
by a narrative description of the study characteristics
presented in the tables, considering the methodological
biases and other problems affecting the interpretation of
study outcomes. Heterogeneity or sources of variability
among study populations, settings, or outcomes will be
explored as an integral part of data synthesis, but as this
work is not meta-analytic, we will use the narrative syn-
thesis to address the applicability of findings across, for
example, professional groups and/or patient behaviours.
A list of excluded studies will also be presented with the
reasons for exclusion.
We will follow the general framework for conducting
narrative synthesis developed by Popay et al. i.e.
Economic and Social Research Council (ESRC) Methods
Programme [52], CRD [48] and Petticrew and Roberts
[53]. These frameworks will be adapted for evidence syn-
thesis from clinical guidelines.
Overview of clinical guidelines and systematic reviews
After this within-stream synthesis, we then want to ask
specific questions about whether evidence from reviews
is reflected in current guidance or whether collated guid-
ance shows areas where better evidence is required.
Whilst our appraisal and extraction methods follow vali-
dated protocols, the ‘higher level’ synthesis of these two
streams in this way is innovative, and we believe will be
a good contribution to knowledge. We will establish the
best evidence for risk assessment and/or preventive in-
terventions and then examine carefully the link between
this review evidence and clinical guidelines. This will
allow us to make recommendations where (a) gaps in
guidance are identified or (b) guidance shows areas
where more evidence is required.
Discussion
This systematic review will identify the best practice for
oral cancer risk factor assessment and preventive inter-
ventions for dental professionals in primary care dental
settings. This study will consider preventive interventions
around common behavioural risk factors (tobacco, alcohol
and HPV/sexual behaviours), recognising the role of
sociodemographic factors. The collation of this evidence
will help to identify gaps in the available clinical guidelines
and the evidence base and gaps in evidence overall. The
study will form the basis for informing the profession in
this important field, by helping design future interven-
tions, research and guidelines where necessary.
Mathur et al. Systematic Reviews  (2015) 4:184 Page 6 of 8
This study is novel in synthesising evidence from both
clinical guidelines and systematic reviews. After conven-
tional synthesis of each stream, we will develop methods
for evidence synthesis across these information sources.
Another strength of this study is that the systematic
search is not limited to oral cancer, thus we do not rule
out good guidelines and/or evidence on how to assess risk
and deliver prevention for these risk factors that may
be aimed at another clinical condition (e.g. periodontal
disease) [44]. Whilst our broad coverage of both guide-
lines and reviews will give a good overview of this im-
portant area, heterogeneity in document type and/or
evidence extracted might limit the ability to make con-
clusive recommendations regarding effective compo-
nents that could be delivered by dental professionals in
regular patient visits.
Dissemination of findings
Findings will be reported using the PRISMA statement
for reporting of systematic reviews and meta-analyses
[54]. The findings will be submitted as part of a thesis
for PhD degree. We will also submit the findings for
publication in a relevant peer-reviewed journal and
present findings in scientific meetings/conferences.
Additional files
Additional file 1: The PRISMA-P 2015 checklist for systematic
review protocols has been completed and uploaded. (DOC 83 kb)
Additional file 2: A list of organizations/databases for searching
clinical guidelines has been uploaded. (DOCX 13.2 kb)
Additional file 3: A sample MEDLINE search strategy has been
uploaded (it will be adapted for other database searches).
(DOCX 12.3 kb)
Additional file 4: Search filters (SIGN and the University of Texas
School of Public Health) to identify systematic reviews and clinical
guidelines has been uploaded. (DOCX 14.7 kb)
Additional file 5: Data extraction form- details of information to be
extracted from systematic reviews and clinical guidelines has been
uploaded. (DOCX 20.7 kb)
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